Insiders Trades
Extendicare Inc. Stock: price and insider trades · Canada
CA·Mcap CA$2.5B
Extendicare Inc.: what insiders have been doing
Every trade that managers of Extendicare Inc. disclose to SEDI is tracked on this page. Between 18 October 2025 and 18 October 2026, 7 insiders published 61 filings.
There is no open-market purchase to report; the filings show 60 sales worth €40.5M by 6 insiders. Biggest ticket of the year: €11.5M, sold by Manji, Samir Aziz and made public on 20 June 2026 (0.59% of market cap).
Typically, a trade is published a median of 2 days after it takes place. That lag is the time during which only the insider knows about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
For context, the typical company on the same exchange (median of 2,120 companies) published 12 filings over the same period, against 61 filings here. Our records for Extendicare Inc. go back to 2026, with no purchases and 60 sales on the open market in total.
Source: insider filings from SEDI. Past trades are no guide to future returns.
Insider Decl.
61
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€40M
60 ops. · all time
Who traded when
BuySaleSamir Aziz Manji55 sales
Jason Richard Horne1 sale
Jillian Elizabeth Fountain1 sale
John Toffoletto1 sale
Kathryn Killoran Bradley1 sale
Rhonda Maureen Chou1 sale
Analyst consensus: bullish or bearish?
Analysts rate Extendicare Inc. Strong Buy (bullish), based on 9 analysts. Average price target: CA$39.83.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 8,127 of 24,148 companies
59.7
score / 100
Value51
Quality68
FCF yld4.1%
Earn yld3.8%
EV/EBITDA15.3x
ROE44%
Gross mgn·
Net mgn5.8%
Debt/EBITDA1.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CA$26.66
Analyst consensus
9 analystsStrong buy
CA$31.50Target CA$39.83(+49%)CA$45.00
Income statement
RevenueCA$1.7B
EBITDACA$186.6M11% margin
Net incomeCA$96.7M6.1% margin
Valuation
PER (trailing)20.4x
PER (forward)16.4x
P/Book6.3x
Beta1.07
Balance sheet & cash
Market capCA$2.5B
Total debtCA$330.2M
Free Cash FlowCA$103.7M
Debt / Equity160%
Profitability & ownership
ROE43.8%
ROA9.4%
% insiders0.5%
% institutions44.4%
Last declaration on 17 August 2026
Declarations61 total
2,330 sharesRights - Performance Share UnitsTSXSEDI:4765118
8,100 shares@ CA$37.46240.010% mcap0.5% of flowCommon SharesTSXSEDI:4751224
5,200 shares@ CA$37.36750.0064% mcap0.3% of flowCommon SharesTSXSEDI:4751221
7,500 shares@ CA$37.46240.0093% mcap0.4% of flowCommon SharesTSXSEDI:4751219
4,800 shares@ CA$37.36750.0059% mcap0.3% of flowCommon SharesTSXSEDI:4751217
4,822 shares@ CA$36.220.0058% mcap100.0% of flowCommon SharesTSXSEDI:4746250
26,000 shares@ CA$37.12840.032% mcap1.5% of flowCommon SharesTSXSEDI:4745592
39,200 shares@ CA$35.92940.047% mcap2.2% of flowCommon SharesTSXSEDI:4745589
2,900 shares@ CA$35.4330.0034% mcap0.2% of flowCommon SharesTSXSEDI:4745587
24,000 shares@ CA$37.12840.030% mcap1.4% of flowCommon SharesTSXSEDI:4745584
36,200 shares@ CA$35.92940.043% mcap2.0% of flowCommon SharesTSXSEDI:4745583
2,700 shares@ CA$35.4330.0032% mcap0.1% of flowCommon SharesTSXSEDI:4745580
19,500 shares@ CA$35.47850.021% mcap1.1% of flowCommon SharesTSXSEDI:4741008
7,800 shares@ CA$35.37170.0084% mcap0.4% of flowCommon SharesTSXSEDI:4741007
59,800 shares@ CA$34.92530.064% mcap3.2% of flowCommon SharesTSXSEDI:4741006
20,800 shares@ CA$34.43260.022% mcap1.1% of flowCommon SharesTSXSEDI:4741005
9,100 shares@ CA$34.18470.0094% mcap0.5% of flowCommon SharesTSXSEDI:4741004
18,000 shares@ CA$35.47850.019% mcap1.0% of flowCommon SharesTSXSEDI:4741003
7,200 shares@ CA$35.37170.0078% mcap0.4% of flowCommon SharesTSXSEDI:4741002
55,200 shares@ CA$34.92530.059% mcap3.0% of flowCommon SharesTSXSEDI:4741001
19,200 shares@ CA$34.43260.020% mcap1.0% of flowCommon SharesTSXSEDI:4741000
8,400 shares@ CA$34.18470.0087% mcap0.4% of flowCommon SharesTSXSEDI:4740999
5,000 shares@ CA$34.000.0053% mcap100.0% of flowCommon SharesTSXSEDI:4738523
551,600 shares@ CA$33.86150.59% mcap28.6% of flowCommon SharesTSXSEDI:4738301
509,200 shares@ CA$33.86150.54% mcap26.4% of flowCommon SharesTSXSEDI:4738300
25 of 61 declarations
About Extendicare Inc.
Extendicare Inc. is a Canadian company that provides health care and support services for seniors. It primarily operates in the long-term care and home care sectors.
